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Microarray profiling emphasizes transcriptomic
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and in vitro cultures
Declan King,1 Paul A. Skehel,2 Owen Dando,2 Katie Emelianova,2 Rona Barron3 and
Thomas M. Wishart4
Primary hippocampal cell cultures are routinely used as an experimentally accessible model platform for the hippocampus and
brain tissue in general. Containing multiple cell types including neurons, astrocytes and microglia in a state that can be readily ana-
lysed optically, biochemically and electrophysiologically, such cultures have been used in many in vitro studies. To what extent the
in vivo environment is recapitulated in primary cultures is an on-going question. Here, we compare the transcriptomic profiles of
primary hippocampal cell cultures and intact hippocampal tissue. In addition, by comparing profiles from wild type and the PrP
101LL transgenic model of prion disease, we also demonstrate that gene conservation is predominantly conserved across genetical-
ly altered lines.
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Introduction
The complex interconnected structure of the mammalian
brain and its anatomical location protected by the skull
presents particular challenges for the study of cellular
and molecular processes. In vitro cell cultures attempt to
recapitulate the basic cellular environment of the brain in
a more experimentally amenable context. Primary hippo-
campal cell cultures are regularly used as a supplement
model to depict the brain’s composition in a readily ac-
cessible and manipulatable arrangement. Indeed, PubMed
currently cites 17 862 publications (1973–2021) associ-
ated with hippocampal cultures, and often strong conclu-
sive inferences are drawn from these studies. Although
these approaches are considered suitable model platforms,
the biological relevance of cultured hippocampal cells to
their in vivo counterparts is still open to question. One
investigation of transcription in dorsal root ganglia and
superior cervical ganglia during neurite outgrowth and re-
generation, described commonalities in gene expression
transcriptomics, relating to regenerating neurons between
in vitro and in vivo models.1 Similar gene expression pro-
files have also been detected in developing hippocampus
in vivo and primary hippocampal neurons undergoing
differentiation both in vivo and in vitro.2–4 Conversely,
genome-wide expression analysis of cell lines has indi-
cated dramatic differences in comparison to relevant tis-
sues of origin.5 Remaining studies are inconclusive and
describe both similarities and differences of biological
processes between neural cells grown in vitro and
in vivo.6 These conflicting results suggest further studies
are required to establish the full utility of cultured hippo-
campal cells as an in vitro model platform. Here, we
compare transcriptomic profiles in acutely dissected
hippocampal tissue and primary hippocampal cell cultures
from both wild type (WT) animals (129/Ola) and a trans-
genic model of neurodegeneration based on the PrP
101LL mutation.
The 101LL model was included in this study as cur-
rently a majority of culture-based studies are being car-
ried out to address questions about the nature of
neuronal stability following specific genetic alterations/
mutations and/or neurodegenerative challenge. We sought
to confirm if the degree of transcriptomic similarity holds
true in murine models genetically altered with a single
amino acid mutation. One such mouse line was available
in our laboratory namely the PrP mutant (101LL, 129/
Ola background)7 containing a single point mutation of
the Prnp gene (proline to leucine, modelling Gerstmann–
Sträussler–Scheinker disease). This 101LL mutation is not
pathological but is known to show altered susceptibility
to disease associated protein misfolding.8 Therefore, in
this current study, we also sought to investigate gene ex-
pression changes in the 101LL model relative to WT.
Findings suggest that RNA isolated from acutely dissected
hippocampal tissue and mature in vitro primary cultures
provided transcriptomic molecular fingerprints that were
not comparable. This was the case for both WT and
101LL genotypes. Direct comparison between genotype
(WT and mutant 101LL) revealed no (tissue) or minimal
(cell) significant transcriptomic changes indicating tran-
script profiles were conserved across WT and 101LL
genotypes.
These findings broaden our understandings of the bio-
logical relevance of cultured hippocampal neurons to
their in vivo tissue counterparts and transcript changes
identified here could be used to drive real progress for fu-
ture therapeutic investigations using in vitro cultures.
Graphical Abstract
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Materials and methods
Mouse lines
All experiments were conducted under Home Office pro-
ject licence (2010–2015 PPL 60-4125: 2015–2017 PPL
70-8523) within the regulations of the Animals (Scientific
Procedures) Act 1986. Study numbers A820 and A821
were approved by Roslin’s Animal Welfare and Ethical
Review Body. WT (129/Ola) mice were obtained from
Jackson laboratories. 101LL knock in transgenic mice
(129/Ola background, single point mutation, proline to
leucine at codon 101 in Prnp gene) were generated in-
house using a double replacement gene targeting strat-
egy.7,9 WT mice were homozygous for the WT Prnp
gene (101PP) and 101LL were homozygous for the
P101L mutation.
Production of primary neuronal cell
cultures
Primary hippocampal neuronal cultures were prepared
based on previously described methods10–16 with minor
modifications indicated below. Day 17 embryos (E17)
were used according to previous protocols.11,17 As this
was a time sensitive protocol, embryos were pooled from
whole litters irrespective to sex. Once dissected hippo-
campi were transferred into 222 ll Trypsin (2.5% 10,
Life Technologies) and 20 ll Deoxyribonuclease I (5 mg/
ml, Sigma) and incubated at 37C for 20 min. The tissue
was then washed twice in 10 ml pre-heated growth media
[500 ml basal medium eagle (Gibco) containing 50 ml
heat inactivated Horse Serum (Gibco), 8 ml 32.5%
Glucose solution (Sigma), 5 ml Sodium Pyruvate 100 mM
(Gibco), 5 ml N2 Supplement (Gibco) and 5 ml Penicillin–
Streptomycin (10 000 U/ml, Gibco)]. Samples were then
disrupted by trituration in growth media and plated on
poly-L-lysine coated six-well plastic dish at a density of
400 000 cells per well (poly-L-lysine, Sigma–Aldrich)
plates. Plates were incubated at 37C/5% CO2 for 4 h.
Growth media was removed and replaced with an equal
volume of serum free media [500 ml neurobasal media
(Gibco), 10 ml B27 supplement 50 (Gibco), 5 ml
L-Glutamine (200 mM, Gibco), 5 ml Penicillin–
Streptomycin (10 000 U/ml, Gibco)]. One-third of media
was replaced with fresh pre-warmed serum free media
every 3 days and cells were cultured to 8 days in vitro
(DIV8).
Immunostaining of primary cultures
Cell media was removed from six-well plates and cells
were incubated with 4% paraformaldehyde (v/v) for
15 min at room temperature. This was followed by three
5-min washes with Dulbecco’s phosphate-buffered saline
containing Ca2þ and Mg2þ (Gibco).
About 1–2 ml of ice-cold methanol was added to the cells
for 10 min with incubation at 20C followed by a 5-min
incubation with 0.3% Triton-X (Sigma, v/v) at room tem-
perature. Again, wells were washed three times in
Dulbecco’s phosphate-buffered saline at 5-min intervals then
blocked for 1 h at room temperature using Fc Block (CD16/
32, BioLegend). Primary antibodies were incubated overnight
in 5% Goat serum (Gibco, v/v) at 4C (concentrations listed
in Table 1). Cells were washed three times in Dulbecco’s
phosphate-buffered saline (Gibco), and secondary antibodies
diluted in 5% goat serum (v/v, Table 1) were added for 1 h
at room temperature in complete darkness followed by a
further three washes as above. Pre-labelled poly-L-lysine six-
well plates (Biocoat Cell Environments) were imaged using a
LSM710 inverted confocal microscope (Zeiss).
Acutely dissected hippocampal
tissues
Hippocampal tissues were obtained from brains of mice
at postnatal Days 6–7. A non-Schedule 1 termination of
each individual postnatal pup involved decapitation fol-
lowed by immediate brain removal and immersion into
RNAlater RNA stabilization Reagent (Qiagen). Tissues
were isolated each time from three pup brains (six hippo-
campi) from the same litter of pups which were then
combined to produce one individual sample. As this was
a time sensitive protocol, brains were pooled irrespective
to gender. This was replicated four times per genotype.
Cell lysis and RNA extraction
Ribonucleic acid (RNA) was extracted from both cell cul-
ture (Day 8, DIV8) and Day 6 mouse hippocampal tissue
samples using the RNeasy Plus Micro Kit (Qiagen)
according to manufacturer’s instructions. The rationale
here was that E17 (assuming gestation period of
Table 1 Primary and secondary antibodies used for immunolabelling experiments
Primary antibody Marker/concentration Secondary/concentration Supplier
Anti-MAP2 (Ab5392) Dendritic, 20 mg/ml, 1/2000 Goat Anti-Chicken IgY (Alexa Fluor 488) 1/500 Both Abcam
Anti-GFAP (Ab53554) Astrocyte, 0.5 mg/ml, 1/500 Donkey Anti-Goat IgG (Alexa Fluor 555) 1/500 Both Abcam
Anti-Iba1 (019–19741) Microglia, 1mgml, 1/1000 Goat Anti-Rabbit IgG (Alexa Fluor 594) 1/500 Wako Abcam
Synapsin 1 (Ab64581) Pre-synaptic, 1 mg/ml, 1/200 Goat Anti-Rabbit IgG (Alexa Fluor 594) 1/200 Both Abcam
PSD-95 (Ab99009) Post-synaptic, 1 mg/ml, 1/200 Goat Anti-Mouse IgG (Alexa Fluor 647) 1/200 Both Abcam
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20–21 days) harvested embryos would be cultured
in vitro for 8 days to provide a more comparable devel-
opmental stage to that of day 6 tissue in vivo cells. For
cell cultures, RNA extractions were always pooled in
cases where more than one well was cultured from the
same batch of embryos and this was counted as one sam-
ple, which was replicated four times per genotype (WT
and 101LL). In total, 16 samples were generated (4 WT
cell, 4 101LL cell, 4 WT tissue and 4 101LL tissue) and
RNA integrity number values of 9 or above were
obtained for each sample (Agilent TapeStation System)
indicating high quality intact RNA was isolated.
Microarray hybridization and
labelling
RNA labelling and hybridization were carried out by
Edinburgh Genomics, University of Edinburgh (https://gen
omics.ed.ac.uk/ Accessed 13 July 2021). For microarray,
cDNA was produced using the Ambion WT expression
kit (Invitrogen) and accordingly labelled using the
GeneChip WT terminal labelling kit (Affymetrix).
Approximately 3mg of fragmented, biotin-labelled
cDNA was hybridised to a Mouse Gene 2.1 ST array
plate (Affymetrix) using the Gene Titan instrument
(Affymetrix) and standard Affymetrix protocols.
Data QC and normalization
Affymetrix microarray processing produced 16 (4 WT cell, 4
101LL cell, 4 WT tissue and 4 101LL tissue) probe cell in-
tensity data files which can be downloaded from https://doi.
org/10.7488/ds/3016 Accessed 13 July 2021. Robust
Multichip Average pre-processing was performed on these
raw microarray intensity datasets for background subtraction,
quantile normalization and summarization, using the R pack-
age ‘oligo’ (R package version 1.52.1).18 A principal compo-
nent analysis (PCA) plot was generated by PCA of log
transformed, normalized expression data, and a clustered
heatmap by calculating the Manhattan distance between sam-
ple pairs. Transcript clusters with very low expression, with
no gene annotation, or with ambiguous gene annotation
were subsequently removed. Differential expression was then
performed using the R package ‘limma’ (R package version
3.44.3)19 (Supplementary material Files 1–4;
1_diff_expr_WT_cell_vs_tissue, 2_diff_expr_101LL_cell_vs_
tissue, 3_diff_expr_cell_WT_ vs_101LL, 4_diff_expr_tissue_
WT_ vs_101LL) and gene ontology (GO) analysis was per-
formed using the R package “topGO” (R package version
2.40.0)20 (Supplementary material Files 5 and 6; 5_go_all_
bp_WT_cell_vs_tissue, 6_go_all_bp_101LL_cell_vs_tissue,
https://doi.org/10.7488/ds/3015 Accessed 13 July 2021).
Standard filtering parameters included false discovery rate
(FDR) P-value <0.05. Ingenuity Pathway Analysis (IPA,
Qiagen) was used to search through gene lists and determine




cDNA samples (16 samples in total, 4 WT culture, 4
101LL culture, 4 WT tissue and 4 101LL tissue) at a
concentration of 25 ng/ll were generated. Mastermix for
real-time quantitative reverse transcription PCR (RT-
qPCR) using Primerdesign was as follows; 1 ml resus-
pended primer mix (300 nM in a 20 ll reaction); 10 ml
2X PrecisionPLUS mastermix; 4 ml RNAse/DNAse free
water. All reactions were carried out using the Stratagene
Mx3005p system and SYBR green mastermix
(Primerdesign/Agilent technologies). Reactions were done
using 96-well PCR plates (ABgene) and optical caps
(Applied Biosystems). Each sample was loaded in tripli-
cate. To identify suitable reference/housekeeping genes,
the GeNorm PCR kit (Primerdesign) was used as
described in manufacture’s protocol. Two cDNA samples
from each representative group (WT, 101LL cultures;
WT, 101LL tissue) were analysed to identify the most
suitable candidate reference gene over all samples for use
in normalization experiments.
Results from the GeNorm PCR kit were analysed using
the Biogazelle qbaseþ analysis software. Analysis results
showed average expression stability of 12 reference tar-
gets ranking according to expression stability. Tyrosine 3-
monooxygenas/tryptophan 5-monooxygenase (Ywhaz)
was stably expressed across all 16 microarray samples
and therefore was selected as reference/housekeeping gene
for all RT-qPCR runs.
Validation experiments
Primers were selected based on target genes of interest
and included Laminin alpha 1 (Lama1), Midline 1
(Mid1), Transforming growth factor beta induced (Tgfbi),
Myocyte Enhancer Factor 2 C (Mef2c) and Transthyretin
(Ttr). Relative changes in gene expression were calculated
using the Delta Delta Ct (DDCT) method.
22,23
IMARIS software analysis of
immunolabelled hippocampal
culture images
IMARIS software (Bitplane) allowed for data visualization
and analysis of confocal microscopy datasets, in the for-
mat ‘czi’. For each image or channel within an image the
intensities of all voxels based on fluorescent signal were
analysed using default standard IMARIS formulas that
calculated mean, standard deviation and sum intensities
(intensities do not have any units) and therefore these
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values were used for relative comparison of targets of
interest across all comparative images.
Statistical analysis
All graphs and statistics were generated in GraphPad
Prism 9. Normality and Lognormality (Anderson–Darling,
D’Agostino–Pearson and Shapiro–Wilk) tests were per-
formed prior to any statistical testing. If data sets passed
the normality test, a one-way ANOVA with Tukey’s/
Sidaks post-hoc was carried out. When data sets did not
pass the normality test a non-parametric Mann–Whitney
test was carried out. For statistical tests, P< 0.05 was
used for significance. All ANOVA tests were presented
with F and P values for main effects.
Significant effects between groups, identified by post-
hoc analysis, were displayed visually on graphs and
recorded in text as P-values. All data were plotted as
means with 95% CI for normal distribution and medians
with 95% CI for non-parametric data.
Data availability statement
Affymetrix microarray probe cell intensity data files and
all differential expression comparison files including GO
analysis have been deposited in The University of
Edinburgh, College of Medicine & Veterinary Medicine,
Royal (Dick) School of Veterinary Studies, The Roslin
Institute, Functional Genetics and Development, DataShare
and are available at: https://doi.org/10.7488/ds/3016
Accessed 13 July 2021 and https://doi.org/10.7488/ds/3015
Accessed 13 July 2021.
Compliance with ethical standards
All applicable international, national and institutional
guidelines for the care and use of animals were followed.
All procedures performed in studies involving animals
were in accordance with the ethical standards of the insti-
tution at which the studies were conducted. The article
does not contain any studies with human participants
performed by any of the authors.
Results
Characterization of neuronal cell
cultures confirm suitability of model
for in vivo comparison
Cultures developed highly branched neuronal networks
by DIV8 (days in vitro, standard timeline is 8 days), evi-
dent from microtubule associated protein 2 immunolabel-
ling and were supported by glia (Fig. 1A–C; G–I).
Neuronal maturity was confirmed by the presence of
both pre (synapsin1) and post-synaptic (PSD-95) protein
markers (Fig. 1D–F; J–L). To investigate if WT and
Figure 1 Characterization of hippocampal cultures
confirmed neuronal maturity. Primary cultures consisted of
mature neuronal networks supported by glial cells. (A–F) WT
cultures. (A) Neuronal populations were present as indicated using
microtubule associated protein 2 (MAP2/Green; DAPI/Blue) and were
supported by glial cells namely astrocytes confirmed by Glial Fibrillary
Acidic Protein immunolabelling (GFAP/Red; DAPI/Blue) (B) and (C)
microglial cells confirmed by Ionized calcium-binding adapter molecule
1 (Iba1/Red; DAPI/Blue). Primary cultures developed into mature
neuronal synaptic networks confirmed by (D) post-synaptic marker,
Anti-Postsynaptic Density protein 95 (PSD-95/White) and (E) Pre-
synaptic marker, Synapsin 1 (Syn1/Red). (F) Merged image of synaptic
markers and MAP2. (G–L) 101LL cultures immunolabelled in same
order as WT. (M) Fluorescent signal data intensity sums generated
from immunolabelled MAP2, Synapsin1 and PSD-95 using IMARIS
based on days in vitro 8 (DIV8) were plotted from both genotypes.
(A–L) Representative WT/101LL cell culture images, DIV8, 30 000
cells plated on PDL plastic plates, Scale bar 50lm (A–B; G-H) 30lm
(C–F; I–L), Zeiss LSM 710. (M) Fluorescent signal data intensity sums,
one-way ANOVA was conducted to compare intensity means of
immunolabelled DIV8 cultures WTand 101LL. There were significant
differences between antibody means as expected F(5,15) ¼ 10.29,
P¼ 0.0002. Sidaks multiple comparison test between groups showed
no significant differences. MAP2 mean difference (md) 3.66Eþ 07;
95% CI of differnece (95% CI) 5.94Eþ 08 to 5.21Eþ 08; Adjusted P-
value (Adj PV) 0.997; Synapsin1 md5.50þ 06; 95% CI 5.62Eþ 08
to 5.51Eþ 08; Adj PV>0.999; PSD-95 md1.88þ 08; 95% CI
7.46Eþ 08 to 3.68Eþ 08; Adj PV 0.758. Graph plotted mean with
95% CI, n¼ 4 WT; n¼ 3 101LL.
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101LL cultures were comparable regarding cellular pro-
file, immunolabelled images of MAP2/Synapsin1/PSD-95
DIV8 cell cultures were processed using IMARIS soft-
ware. Data intensity comparisons established from fluor-
escent signal for each target protein showed no
significant differences between WT and 101LL cell cul-
tures indicating both had similar cellular profiles (Fig.
1M). This also reinforced reproducibility of the culture
method used across genotype. Overall, these cultures
were similar to those reported in the literature17,24,25 and
were appropriate for use in the comparative molecular
fingerprinting experiments proposed here.
Microarray profiling establishes
transcriptomic differences between
hippocampal in vivo tissue and
in vitro cell cultures comparisons
The microarray platform was employed here to compare
gene expression in both in vitro hippocampal cell culture
and in vivo hippocampal tissue RNA extracts to establish
to what extent these contexts were or were not compar-
able. A PCA plot (first and second components) gener-
ated from microarray analysis of all 16 in vivo and
in vitro samples (4 WT cell, 4 101LL cell, 4 WT tissue
Figure 2 Microarray analysis highlighting transcriptomic profile differences exist between hippocampal in vivo tissue and
in vitro cell cultures. (A) Principal component analysis (PCA) plot of log-transformed expression data demonstrates clear separation in
sample distribution between in vivo and in vitro platforms suggesting both are not comparable on a transcriptomic level. Both WTand 101LL
genotypes correlated in a similar fashion irrespective of context. (B) Clustering heatmap for all 16 calibrated samples clearly demonstrated a
difference in gene expression patterns existed between cell (upper, dark blue) and tissue samples (lower, light blue). (C) Scatter plot of WT
cell versus tissue was constructed to ascertain the magnitude of gene changes between platforms. All genes (represented by individual dots/
triangles) above the dotted horizontal line passed the standard filtering parameters (FDR P-value 0.05, log 1.3) and therefore were
significant. In this case, 5199 differentially expressed genes (DEGs) were identified of which 2706 were down regulated and 2493 were
upregulated. Applying more restrictive filtering to include a fold change (FC) of two represented here by the dotted vertical lines (1, 1 log2),
830 DEGs were identified (682 down/green; 148 up/red). (D) 101LL cell versus tissue produced a similar scatter profile where 4677 (2527
down, 2150 up) were identified at FDR P-value 0.05. When including FC2 this number was reduced to 856 DEGs (660 down/green and 196
up/red). For both graphs, top 20 gene names (based on P-value/FC) are displayed and highlight similar gene changes were occurring across
genotypes.
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and 4 101LL tissue) was used to visualize patterns associ-
ated with these datasets (Fig. 2A).
The visualization plot generated confirmed a clear pat-
tern and separation was evident between cell (orange)
and tissue (blue) groups of arrays analysed by principal
component. This was independent of genotype.
These observations were further supported by clustering
all 16 samples on a heatmap (Fig. 2B), where again dif-
ferences in gene expression patterns were evident between
cell and tissue platforms. To ascertain the magnitude of
gene changes between in vivo and in vitro, standard fil-
tering of datasets was carried out using an FDR P-value
of <0.05. To visualize these changes, scatter graphs were
produced accordingly. Scatter plots of both WT cell ver-
sus tissue and 101LL cell versus tissue (Fig. 2C and D)
clearly show numerous differentially expressed genes
(DEGs) were detected using standard filtering parameters
(FDR P-value <0.05). Here each dot/triangle resembles a
single gene, genes above the dotted horizonal line were
significantly changed. For WT cell versus tissue 5199
DEGs (2706 down and 2493 up) were detected (Fig. 2C).
When applying additional fold change parameters of two
(donated by dotted vertical lines) 830 DEGs were
detected of which 682 were downregulated and 148 were
upregulated. In comparison, 101LL cell versus tissue pro-
duced similar results with 4677 DEGs identified (2527
down and 2150 up) at FDR P-value <0.05 (Fig. 2D).
When a fold change of two was included, this number
was decreased to 856 DEGs (660 down and 196 up). As
highlighted on both scatter graphs similar genes were
changing across both genotypes, including downregula-
tion of Adgrl4, Atp13a5, Car4 and upregulation of
Bace2, Car14, Ephx1.
Comparison of 101LL versus WT tissue identified no
DEGs using P-value <0.05 indicating the single point
mutation in the Prnp gene did not change baseline tran-
script profile in vivo. Whilst comparing 101LL versus
WT cell, 5 DEGs were identified, and all were upregu-
lated in the 101LL genotype. One of these genes namely
Midline 1 (Mid1), is associated with microtubule stabil-
ization26 suggesting that neurons may be less stable in
the 101LL genotype thus, increasing expression of Mid1
may be protective. Indeed, it is known that these trans-
genic animals show altered susceptibility to disease and
this may well explanation observations here.8
Collectively, it is evident here that baseline transcriptomic
profiles are analogous between WT murine models and
genetically altered models with a single amino acid
mutation.
IPA highlights multiple affected
pathways
To investigate biological functions associated with DEGs
identified and the pathways they influence, significantly
filtered datasets from both WT and 101LL cell versus tis-
sue were analysed using topGO and IPA. Biological GO
terms identified using topGO were numerous
(Supplementary material File 5 and 6, https://doi.org/10.
7488/ds/3015 Accessed 13 July 2021) and were compar-
able across WT cell versus tissue and 101LL cell versus
tissue datasets.
Briefly, top biological processes identified in vitro and
similar to both datasets included the following, adenylate
cyclase-activating G protein-coupled receptor signalling
pathway, MAPK cascade, learning or memory, long-term
synaptic potentiation and calcium ion transport which
were all downregulated. Biological processes upregulated
in vitro included cholesterol biosynthetic process, regula-
tion of cell growth, forebrain neuron development, regu-
lation of Wnt signalling pathway and endoplasmic
reticulum unfolded protein response. IPA also provided
an alternative means of data analysis and interpretation.
This software is built on a very comprehensive and
manually curated knowledge database and therefore pro-
vides unique capabilities to identify the most significant
pathways, whether activated or inhibited from our experi-
mental data. Evidence from Fig. 3A (FDR P-value <0.05)
shows top canonical pathways identified in IPA are con-
served between genotypes and are predominantly inhib-
ited/downregulated in vitro. Canonical pathways
identified here complement topGO results where neuro-
transmission, cell signalling, and memory were all inhib-
ited in vitro. Activated pathways are associated with
cholesterol synthesis Wnt signalling and ER unfolded pro-
tein response. To gain further insights into gene expres-
sion changes in our datasets we included a heatmap of
the top 20 upstream regulators (Fig. 3B). Here, we show
genes identified were consistently expressed across both
WT cell versus tissue and 101LL cell versus tissue.
The most significant canonical pathway identified was
CREB signalling in neurons and this was shown to be
inhibited in vitro (Fig. 3A). The CREB as a nuclear tran-
scription factor binds to CRE (cAMP response element,
which is also shown the be inhibited in vitro), and regu-
lates transcription activity of its downstream substrates.
This in turn regulates neuronal processes, including me-
tabolism and survival. Several gene changes were identi-
fied in this cascade and as shown in Fig. 3C were all
predominantly downregulated.
Validation experiments
Microarray expression results (Table 2) were validated
using RT-qPCR based on significant DEGs identified
(Lama1, Mid1 and Tgfbi) in the 101LL versus WT cell
cohort (Fig. 4A). For completeness and robustness add-
itional genes that were either downregulated (Mef2c) or
not changed between comparisons (Ttr) were also
included in this validation. As evident from Fig. 4B–F
similar expression trends between all comparisons were
found using RT-qPCR thus validating microarray data,
and confirming results presented here were accurate.
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Figure 3 IPA identified numerous canonical pathway changes in vitro. (A) Using standard filtering parameters (P-value <0.05), across both
WT cell versus tissue and 101LL cell versus tissue datasets, IPA generated a list of canonical pathways of which the top significant 20 are listed here
(filtered specifically for brain related pathways). Boxes in blue donate pathways that were inhibited and boxes in orange donate activated pathways.
(B) Top 20 upstream regulators display gene consistency across comparisons. (C) CREB signalling in neurons was identified as the most significantly
changed canonical pathway in these dataset comparisons and here we show the specific genes involved in this CREB signalling cascade.
Table 2 Gene fold changes identified from microarray analysis matched RT-qPCR expression profiles exactly
Gene LogFC 101LL v WT cell Adjusted P-value RT-qPCR Mann–Whitney
Lama1 2.10 0.04 0.03
Mid1 2.93 0.01 0.03
Tgfbi 2.48 0.03 0.03
Mef2c 0.67 0.13 0.03
Ttr 0.98 0.93 0.99
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Discussion
This study has attempted to address the lack of data detail-
ing the molecular composition of cell culture platforms used
to model and infer upon their intact in vivo neuronal
counterparts. Studies by others have attempted similar inves-
tigations, however, direct comparisons between identical gen-
otypes from both in vivo and in vitro contexts was never
carried out, instead separate studies were combined to study
transcriptomic changes between both. For example, one
Figure 4 Validation of microarray expression datasets. (A) Comparing 101LL versus WT cell 5 DEGs (FDR P-value <0.05) were
identified by microarray analysis (all upregulated in 101LL genotype). Gene names displayed on scatter graph for clarity (above the horizontal
dotted line donates significant genes FDR P-value <0.05, and above vertical dotted line fold change of two). (B–D) RT-qPCR validation of
selected genes namely Lama1, Mid1 and Tgfbi. Profiles shown here match microarray data profiling. (E–F) Mef2c a downregulated gene and Ttr
an unchanged gene was also included in validation for robustness. Both genes again validated microarray data. RT-qPCR reference gene Ywhaz,
fold changes from RT-qPCR were calculated using 2-DDCt method. Nonparametric Mann–Whitney t-tests were carried out in all cases,
graphs plotted as median with 95% CI, n¼ 4, n ¼ individual samples. Note for Ttr 101LL cell n¼ 3.
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study focussed on murine gene expression in developing
hippocampus in vivo,2 and a second study on expression
profiling of primary hippocampal neurons undergoing differ-
entiation in vitro.3,4 Both studies were then combined for
subsequent comparisons. Results showed in vitro and in vivo
expression profiles were similar. These findings contradict
the results presented here however their study was compar-
ing primary cultures obtained from CD1 outbred mice which
have more genetic diversity4 with hippocampal tissue from
C57BL/6 inbred mice which are almost genetically identical.2
Therefore, these studies did not represent an accurate direct
comparison of in vitro and in vivo platforms. Another study
using a similar approach (combining two separate studies)
described both similarities and differences of biological proc-
esses between neural cells grown in vitro and in vivo.6
However, these results were based on rat neural cells
obtained from commercial sources (in vitro) compared to
mouse acutely purified neural cells (in vivo), implying these
data involved studying cross-species transcriptomic compari-
sons. Thus, although in vitro and in vivo comparisons have
been carried out previously, the studies were restrictive.
Studies presented in both the introduction and here in
the discussion suggest complex in vivo tissues consisting of
multiple cell types have similar gene expression profiles to
neuronal cultures. These findings are questionable as dif-
ferences in in vitro cultures would be expected due to the
simplicity of the platform where many of these transcrip-
tional changes would be driven by the emission of cell
types present in vivo. In this study, a direct comparison
between in vivo/in vitro models and genotype was done
and as expected changes in gene expression between
organized in vivo tissues were detected. However, for a
more accurate transcriptional profile comparison, single-
cell RNA-seq comparing gene expression of individual cell
types such as neurons between both in vivo and in vitro
platforms could be carried out and this was a limitation
of our study here which only used bulk RNA-seq.
Gene expression changes presented here indicated that
primary hippocampal cultures and acutely dissected hip-
pocampal tissues were not comparable and numerous
biological pathways were perturbed in vitro. Pathways
relating to memory again would be expected to be inhib-
ited in cultures as shown here however many other path-
ways relating to a broad range of biological pathways
were also disturbed including neurotransmission, cell sig-
nalling, cholesterol synthesis, Wnt signalling and ER
unfolded protein response. Again, studies utilizing
in vitro platforms to study such pathways should be cau-
tious in their interpretations of results.
Interestingly, gene expression was not altered between
WT and mutant genotype (apart from 5 DEGs in cell)
indicating a single amino acid mutation may not alter de-
tectable transcriptomic changes between transgenic and
WT models. Thus, by comparing profiles from WT and
the PrP 101LL transgenic model of prion disease, we
demonstrate that gene conservation is predominantly con-
served across genetically altered lines. It is possible by
using other technologies further transcriptional changes
could be detected as microarray hybridization is restricted
to predefined transcripts/genes and this is one limitation
of the study presented here. RNA-sequencing, for ex-
ample, could profile the entire transcriptome of these
models and therefore could be used to detect more subtle
transcriptional changes.
In conclusion, we have shown adequate evidence that
primary hippocampal cultures are significantly different
to their in vivo tissue counterparts at a transcriptional
level, and one should be cautious when planning and
interpreting data from primary cultures. This study also
provides a unique transcriptome resource and a list of ca-
nonical pathways that are significantly altered in vitro.
These insights should help in future experimental plan-
ning or to re-access previously published data based on
neuronal cell culture models.
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